CXCR4 Expression Accounts for Clinical Phenotype and Outcome in Acute Myeloid Leukemia

被引：23
作者：
Mannelli, Francesco [1 ]
Cutini, Ilaria
Gianfaldoni, Giacomo
Bencini, Sara
Scappini, Barbara
Pancani, Fabiana
Ponziani, Vanessa
Bonetti, Maria Ida
Biagiotti, Caterina
Longo, Giovanni
Bosi, Alberto
机构：
[1] Ist Toscano Tumori, I-50134 Florence, Italy
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2014年 / 86卷 / 05期
关键词：
acute myeloid leukemia; immunophenotype; CXCR4; NPM1; prognosis; CHEMOKINE RECEPTOR CXCR4; STEM-CELL NICHE; MUTATIONS; OVEREXPRESSION; CLASSIFICATION; PROGNOSIS; ADVERSE; NPM1;
D O I：
10.1002/cyto.b.21156
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Background: In acute myeloid leukemia (AML), CXCR4 expression has been correlated with leukocytosis and prognosis. Methods: We quantified CXCR4 expression by flow cytometry on leukemic cells in 142 AML patients. Results: We confirm a correlation between high CXCR4 expression and leukemic burden. Furthermore, we documented a correlation with platelet count, dysplastic megakaryopoiesis, hepato-splenomegaly and extra-hematological disease. NPM1-mutated AML displayed a significantly higher intensity of CXCR4 compared to NPM1-wt cases: it is conceivable its clinical phenotype to be driven by high CXCR4 expression. Conclusions: CXCR4 expression resulted in an independent prognostic factor. Our data support CXCR4 targeting as a potential therapeutic strategy. (C) 2014 International Clinical Cytometry Society
引用
收藏
页码：340 / 349
页数：10
相关论文
共 36 条
  • [11] The hematopoietic stem cell niche-home for friend and foe?
    Krause, Daniela S.
    Scadden, David T.
    Preffer, Frederic I.
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84B (01) : 7 - 20
  • [12] A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
    Labbaye, Catherine
    Spinello, Isabella
    Quaranta, Maria Teresa
    Pelosi, Elvira
    Pasquini, Luca
    Petrucci, Eleonora
    Biffoni, Mauro
    Nuzzolo, Eugenia Rosa
    Billi, Monia
    Foa, Robin
    Brunetti, Ercole
    Grignani, Francesco
    Testa, Ugo
    Peschle, Cesare
    [J]. NATURE CELL BIOLOGY, 2008, 10 (07) : 788 - 801
  • [13] Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia
    Lacombe, F
    Durrieu, F
    Briais, A
    Dumain, P
    Belloc, F
    Bascans, E
    Reiffers, J
    Boisseau, MR
    Bernard, P
    [J]. LEUKEMIA, 1997, 11 (11) : 1878 - 1886
  • [14] Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
    Li, YM
    Pan, Y
    Wei, YK
    Cheng, XY
    Zhou, BHP
    Tan, M
    Zhou, XY
    Xia, WY
    Hortobagyi, GN
    Yu, DH
    Hung, MC
    [J]. CANCER CELL, 2004, 6 (05) : 459 - 469
  • [15] Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
    Malcovati, Luca
    Della Porta, Matteo G.
    Pietra, Daniela
    Boveri, Emanuela
    Pellagatti, Andrea
    Galli, Anna
    Travaglino, Erica
    Brisci, Angela
    Rumi, Elisa
    Passamonti, Francesco
    Invernizzi, Rosangela
    Cremonesi, Laura
    Boultwood, Jacqueline
    Wainscoat, James S.
    Hellstrom-Lindberg, Eva
    Cazzola, Mario
    [J]. BLOOD, 2009, 114 (17) : 3538 - 3545
  • [16] Mitelman F., 1995, ISCN 1995 INT SYSTEM
  • [17] Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)
    Möhle, R
    Failenschmid, C
    Bautz, F
    Kanz, L
    [J]. LEUKEMIA, 1999, 13 (12) : 1954 - 1959
  • [18] Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
    Noguera, NI
    Ammatuna, E
    Zangrilli, D
    Lavorgna, S
    Divona, M
    Buccisano, F
    Amadori, S
    Mecucci, C
    Falini, B
    Lo-Coco, F
    [J]. LEUKEMIA, 2005, 19 (08) : 1479 - 1482
  • [19] Validation and quality control of immunophenotyping in clinical flow cytometry
    Owens, MA
    Vall, HG
    Hurley, AA
    Wormsley, SB
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 243 (1-2) : 33 - 50
  • [20] IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
    Paschka, Peter
    Schlenk, Richard F.
    Gaidzik, Verena I.
    Habdank, Marianne
    Kroenke, Jan
    Bullinger, Lars
    Spaeth, Daniela
    Kayser, Sabine
    Zucknick, Manuela
    Goetze, Katharina
    Horst, Heinz-A.
    Germing, Ulrich
    Doehner, Hartmut
    Doehner, Konstanze
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3636 - 3643
1234